meRfi®-GM
Nosocomial Infection
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Nosocomial infections, also known as hospital-acquired infections (HAIs), are a significant concern in healthcare settings worldwide. These infections are acquired during hospital stays and can lead to increased morbidity, mortality, and healthcare costs.
see also:
Enterococcus
Nosocomial pneumonia / Hospital-acquired pneumonia
Staphylococcus aureus bacteraemia
…
References (Sources)
- Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?
- Attributable mortality of nosocomial candidemia, revisited
- Methicillin-resistant Staphylococcus aureus nosocomial pneumonia: role of linezolid in the People’s Republic of China
- Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study
- Nosocomial methicillin-resistant staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy
- Reductions in intestinal Clostridiales precede the development of nosocomial Clostridium difficile infection